SEC Form 4 · accession 0001104659-16-106698
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald J Hayden Jr.
Director
Period of report
Mar 21, 2016
Accepted (ET)
Mar 21, 2016 · 9:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2016 | M | 1,935 | $3.45 | A | 1,935 | D | |
| Common Stock | Mar 21, 2016 | M | 14,195 | $3.45 | A | 14,195 | D | |
| Common Stock | Mar 21, 2016 | S | 16,130 | $7.42 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $3.45 | Mar 21, 2016 | M | 1,935 | D | — | Mar 28, 2016 | Common Stock | 1,935 | 0 | D |
| Stock Option (Right to Buy)F3 | $3.45 | Mar 21, 2016 | M | 14,195 | D | — | Mar 28, 2016 | Common Stock | 14,195 | 0 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015.
- F2The option vested over three years of service following March 29, 2006, with 50% vesting upon completion of one year of service and in 2 equal annual installments thereafter.
- F3The option vested over four years of service following March 29, 2006, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.